Neurotrophic Factors in Central Nervous System Trauma

Journal of Neurotrauma

Volumn 12, Issue 5, 1995, Pages 853-870

  Mocchetti, Italo ^a   Wrathall, Jean R ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bFGF; neurotrophic factor expression; neurotrophic therapy; NGF; p75NGFR; spinal cord injury; trk

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CLENBUTEROL; FIBROBLAST GROWTH FACTOR RECEPTOR; GANGLIOSIDE GM1; GLUCOCORTICOID; INTERLEUKIN 1; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; STAUROSPORINE;

BRAIN INJURY; CELL SURVIVAL; GENE EXPRESSION; HUMAN; NERVE CELL LESION; NERVE FIBER GROWTH; NONHUMAN; REVASCULARIZATION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; TRANSCRIPTION REGULATION;

ANIMAL; BRAIN; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM DISEASES; HUMAN; NERVE GROWTH FACTORS; SPINAL CORD; SPINAL CORD INJURIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028858281     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.1995.12.853     Document Type: Article

References (186)

1. ABRAHAM, J.A., WHANG, J.L., TUMOLO, A., et al. (1986). Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J. 5, 2523-2528.
2. ALDERSON, R.F., ALTERMAN, A.L., BARDE, Y.A., and LINDSAY, R.M. (1990). Brain-derived neurotrophic factor increases survival and differentiated function of rat septal cholinergic neurons in culture. Neuron 5, 297-306.
3. ALTAR, A.C., BOYLAN, C.B., JACKSON, C., et al. (1992a). Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal turnover in vivo. Proc. Natl. Acad. Sci. U.S.A. 89, 11347-11351.
4. ALTAR, A.C., ARMANINI, M., DUGICH-DJORDJEVIC, M., et al. (1992b). Recovery of cholinergic phenotype in the injured rat neostriatum: role for endogenous and exogenous nerve growth factor. J. Neurochem. 59, 2167-2177.
5. ANDERSON, K.J., DAM, D., LEE, S., and COTMAN, C.W. (1988). Basic fibroblast growth factor prevents death of le-sioned cholinergic neurons in vivo. Nature (London) 332, 360-361.
6. ARMSTRONG, R.C., and MONTMINY, M.R. (1993). Transsynaptic control of gene expression. Annu. Rev. Neurosci. 16, 17-29.
7. ASAI, T., WANAKA, A., KATO, H., MASANA, Y., SEO, M., and TOHYAMA, M. (1993). Differential expression of two members of FGF receptor family, FGFR-1 and FGFR-2 mRNA in the adult rat central nervous system. Mol. Brain Res. 17, 174-178.
8. BAKHIT, C., ARMANINI, M., WONG, W.L.T., BENNETT, G.L., and WRATHALL, J.R. (1991). Increase in nerve growth factor-like immunoreactivity and decrease in choline
9. acetyltransferase activity following contusive spinal cord. Brain Res. 554, 24-271.
10. BARB ANY, G., and PERSSON, H. (1992). Regulation of neu-rotrophin mRNA expression in the rat brain by glucocorticoids. Eur. J. Neurosci. 4, 396-403.
11. BECK, K.D., KNUSEL, B., WINSLOW, J.W., ROSENTHAL, A., and BURTON, L.E. (1992). Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuate toxicity of l-methyl-4-pyridinium. Neurodegeneration 1, 27-36.
12. BECK, K.D., VALVERDE, J., ALEXI, T., et al. (1995). Mesencephalic dopaminergic neurons protected by gdnf from axotomy-induced degeneration in the adult brain. Nature (London) 373, 339-341.
13. BLIGHT, A.R. (1993). Remyelination, revascularization, and recovery of function in experimental spinal cord injury. Adv. Neurol. 59, 91-104.
14. BRACKEN, M.B., SHEPARD, M.J., COLLINS, W.F., et al. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N. Engl. J. Med. 322, 1405-1411.
15. BRUNELLO, N., REYNOLDS, M., WRATHALL, J.R., and MOCCHETTI, I. (1990). Increased nerve growth factor receptor mRNA in injured spinal cord. Neurosci. Lett. 118, 238-240.
16. BURGESS, W., and MACIAG, T. (1989). The heparin-binding growth factor family of proteins. Annu. Rev. Biochem. 58, 575-590.
17. CADAY, C.G., KLAGSBURGN, M., FANNIONG, P.J., MIRZABEGIAN, A., and FINKLESTEIN, S.P. (1990). Fibroblast growth factor levels in the developing rat brain. Dev. Brain Res. 52, 241-246.
18. CHAO, M.V. (1992). Neurotrophin receptors: A window into neuronal differentiation. Neuron 9, 583-593.
19. CHAO, M.V. (1994). The p75 neurotrophin receptor. J. Neurobiol. 25, 1373-1385.
20. CHAO, M.V., BOTHWELL, M.A., ROSS, A.H., et al., (1986). Gene transfer and molecular cloning of the human NGF receptor. Science 232, 41S-A21.
21. CHENG, B., and MATTSON, M.P. (1991). NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7, 1031-1041.
22. CHENG, B., BARGER, S.W., and MATTSON, M.P. (1994). Staurosporine, K-252a, and K-252b stabilize calcium homeostasis and promote survival of CNS neurons in the absence of glucose. J. Neurochem. 62, 1319-1329.
23. CHOI, D.W. (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
24. CLARY, D.O., and REICHARDT, L.F. (1994). An alternative spiced form of the nerve growth factor receptor trkA confers an enhanced response to neurotrophin 3. Proc. Natl. Acad. Sci. U.S.A. 91, 11133-11137.
25. COLANGELO, A.M., FINK, D., RABIN, S.J., and MOC-CHETTI, I. (1994). Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene. Glia 12, 117-127.
26. COLANGELO, A.M., PANI, L., and MOCCHETTI, I. (1995). Correlation between increased AP-1Ngf binding activity and induction of nerve growth factor transcription by multiple signal transduction pathways in C6-2B glioma cells. Mol. Brain Res. (in press).
27. COLLARINI, E.J., and RICHARDSON, W.D. (1993). Growth factor for myelinating glial cells in the central and peripheral nervous system, in: Neurotrophic Factors. S.E. Loughlin and J.H. Fallon (eds.). Academic Press: San Diego, CA.
28. COWIE, A., IVANCO, T.L., and FAHNESTOCK, M. (1994). Mouse NGF promoter upstream sequences do not affect gene expression in mouse fibroblasts. Mol. Brain Res. 27, 58-62.
29. CUELLO, A.C., GAROFALO, L., KENIGSBERG, R.L., and MAYSINGER, D. (1989). Gangliosides potentiates in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc. Natl. Acad. Sci. U.S.A. 86, 2056-2060.
30. CURRAN, T., and FRANZA, R.B. (1988). Fos and Jun: The AP-1 connection. Cell 55, 395-397.
31. DAVIES, A., LEE, K-F., and JAENISH, R. (1993). p75-defi-cient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins. Neuron 11, 1-20.
32. DELOULME, J.C., GENSBURGER, C., SARHAN, S., SEILER, N., and SENSENBRENNER, M. (1991). Effects of basic fibroblast growth factor on the development of GABAergic neurons in culture. Neuroscience 42, 561-568.
33. DIENER, P., and BREGMAN, B.S. (1994). Neurotrophic factors prevent the death of CNS neurons after spinal cord lesions in newborn rats. NeuroReport 5, 1913-1917.
34. DIONNE, C.A., CRUMLEY, G., BELLOT, F., et al. (1990). Cloning and expression of two distinct high-affinity receptor cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 9, 2685-2692.
35. D-MELLO, S.R., and HEINRICH, G. (1991). Structural and functional identification of regulatory regions and cis elements surrounding the nerve growth factor gene promoter. Mol. Brain Res. 11, 255-264.
36. DOBROWSKY, R.T., WERNER, M.H., CASTELLINO, A.M., CHAO, M.V., and HANNUN, Y.A. (1994). Activation of the sphingomyelin cycle through the low affinity neurotrophin receptor. Science 265, 1596-1598.
37. EBENDAL, T., PERSSON, H., and OLSON, L. (1991). New directions in NGF experimental therapy of Alzheimers disease, in: Cholinergic basis for Alzheimer therapy. R. Becker and E. Giacobini (eds.). Birkhauser: Boston, MA, 468-473.
38. ECKENSTEIN, F.P. (1994). Fibroblast growth factor in the nervous system. J. Neurobiol. 25, 1467-1480.
39. ECKENSTEIN, F.P., SHIPLEY, G.D., and NISHI, R. (1991). Acidic and basic fibroblast growth factor in the nervous system: Distribution and differential alteration of levels after injury of central versus peripheral nerve. J. Neurosci. 11, 412-419.
40. EMOTO, N., GONZALES, A-M., WALICKE, P.A., et al., (1989). Basic fibroblast growth factor in the central nervous system: Identification of specific loci of basic FGF expression in the rat brain. Growth Factors 2, 21-29.
41. ERNFORS, P., HENSCHON, A., OLSON, L., and PERSSON, H. (1989). Expression of nerve growth factor receptor mRNA is developmental regulated and increased after axotomy in rat spinal cord motoneurons. Neuron 2, 1605-1613.
42. ERNFORS, P., LONNERBERG, P., AYER-LELIEVRE, C., and PERSSON, H. (1990). Developmental and regional expression of basic fibroblast growth factor mRNA in the rat central nervous system. J. Neurosci. Res. 27, 10-15.
43. FABRAZZO, M., COSTA, E., and MOCCHETTI, I. (1991). Reserpine stimulates nerve growth factor biosynthesis in developing rats brain: steroids as possible mediators. Mol. Pharmacol. 39, 144-149.
44. FADEN, A.I. (1993). Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol. 7, 175-186.
45. FADEN, A.I., and SALZMAN, S. (1992). Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13, 29-35.
46. FADEN, A.I., DEMEDIUK, P., PANTER, S.S., and VINK, R. (1989). The role of excitatory amino acid and NMD A receptors in traumatic injury. Science 244, 798-800.
47. FAVARON, M., MANEV, H., ALHO, H., et al. (1988). Gangliosides prevent glutamate neurotoxicity in primary cultures of neonatal rat cerebellar and cortex. Proc. Natl. Acad. Sci. U.S.A. 85, 7351-7355.
48. FERGUSON, I.A., and JOHNSON, E.M. (1991). Fibroblast growth factor receptor-bearing neurons in the CNS: Identification by receptor-mediated retrograde transport. J. Comp. Neurol. 313, 693-706.
49. FERNANDEZ-SANCHEZ, M.T., and NOVELLI, A. (1993). Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated toxicity. FEBS Lett. 335, 124-131.
50. FERRARI, G., FABRIS, M., and GORIO, A. (1983). Gangliosides enhance neurite outgrowth in PC 12 cells. Dev. Brain Res. 8, 215-222.
51. FERRARI, G., MINOZZI, M.C., TOFFANO, G., LEON, A., and SKAPER, S.D. (1989). Basic fibroblast growth promotes the survival and development of mesencephalic neurons in culture. Dev. Biol. 133(1), 140-147.
52. FERRARI, G., BATISTAOU, A., and GREENE, L.A. (1993). Gangliosides rescue neuronal cells from death after trophic factor deprivation. J. Neurosci. 13, 1879-1887.
53. FINKLESTEIN, P., APOSTOLIDES, P.J., CADAY, C.G., PROSSER, J., PHILIPS, M.F., and KLAGSBRUN, M. (1988). Increased basic fibroblast growth factor immunore-activity at the site of focal brain wound. Brain Res. 460, 253-259.
54. FISHER, W., WICTORIN, K., BJORKLUND, A., WILLIAMS, L.R., VARON, S., and GAGE, F.H. (1987). Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature (London) 329, 65-68.
55. FOLLESA, P., and MOCCHETTI, I. (1993). Regulation of basic fibroblast growth factor and nerve growth factor mRNA by adrenergic receptor activation and adrenal steroids in rat CNS. Mol. Pharmacol. 43, 132-138.
56. FOLLESA, P., WRATHALL, J.R., and MOCCHETTI, I. (1994a). Induction of bFGF mRNA in spinal cord trauma. Mol. Brain Res. 22, 1-8.
57. FOLLESA, P., GALE, K., and MOCCHETTI, I. (1994b). Regional and temporal pattern of expression of nerve growth factor and basic fibroblast growth factor mRNA in rat brain following electroconvulsive shock. Exp. Neurol. 127,37-44.
58. FREESE, A., FINKLESTEIN, S.P., and DIFIGLIA, M. (1992). Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity. Brain Res. 575, 351-355.
59. FRIDEN, P.M., WALUS, L.R., WATSON, P., et al. (1993). Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259, 373-377.
60. FRIM, D.M., UHLER, T.A., SHORT, P.M., et al. (1993). Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. NeuroReport 4, 367-370.
61. FRISEN, J., VERGE, M.K., CULLHEIM, S., et al. (1992). Increased levels of trkB mRNA and trkB protein-like immunoreactivity in the injured rat and cat spinal cord. Proc. Natl. Acad. Sci. U.S.A. 89, 11282-11286.
62. GALE, K., KERASIDIS, H., and WRATHALL, J.R. (1985). Spinal cord contusion in the rat: Behavioral analysis of functional neurologic impairement. Exp. Neurol. 88, 123-134.
63. GALL, C.M., and ISACKSON, P.J. (1989). Limbic seizure increase neuronal production of messenger RNA for nerve growth factor. Science 245, 758-761.
64. GALL, C.M., BERSCHAUER, R., and ISACKSON, P.J. (1994). Seizures increase basic fibroblast growth factor mRNA in adult rat forebrain neurons and glia. Mol. Brain Res. 21, 190-205.
65. GEISLER, F.H., DOERSEY, F.C., and COLEMAN, W.P. (1991). Recovery of motor function after spinal cord injury-a randomized placebo-controlled trial with GM-1 ganglio-side. N. Engl. J. Med. 324, 1829-1838.
66. GIBBS, R.B., CHAO, M.V., and PFAFF, D.W. (1991). Effects of fimbria-fomix and angular bundle transection on expression of the p75NGFR mRNA by cells in the medial septum and diagonal band of Broca: Correlation with cell survival, synaptic reorganization and sprouting. Mol. Brain Res. 11, 207-219.
67. GODFRAIN, C., FRIEDIRICH, V.L., HOLMES, K.V., and DUBOIS-DALCQ, M. (1989). In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J. Cell Biol. 109, 2405-2416.
68. GOLDFARB, M. (1990). The fibroblast growth factor family. Cell Growth Differ. 1, 439-445.
69. GOMEZ-PINILLA, F., TRAM, H., COTMAN, C.W., and NI-ETO-SAMPEDRO, M. (1989). Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury. Exp. Neurol. 104, 118-124.
70. GOMEZ-PINILLA, F., LEE, J.W-K., and COTMAN, C.W. (1992). Basic FGF in adult rat brain: Cellular distribution and response to entorhinal lesion and fimbria-fomix transection. J. Neurosci. 12, 345-355.
71. GOTZ, R., KOSTER, R., WINKLER, C., et al., (1994). Neurotrophin-6 is a new member of the nerve growth factor family. Nature (London) 372, 266-269.
72. HADJICONSTANTINOU, M., and NEFF, N.H. (1988). Treatment with GM1 ganglioside restores dopamine in the 2-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-treated mouse. J. Neurochem. 51, 1190-1198.
73. HAGG, T., FASS-HOLMES, B., VAHLSING, H.L., MAN-THORPE, M., and VARON, S. (1989). Nerve growth factor reverses axotomy-induced decreases in choline acetyltrans-ferase. NGF receptor and size of medial septum cholinergic neurons. Brain Res. 505, 29-38.
74. HALLBOOK, F., IBANEXZ, C.F., and PERSSON, H. (1991). Evolutionary studies of the nerve growth factor family reveal a novel member abundant expressed in Xenopus ovary. Neuron 6, 845-858.
75. HAYES, V.Y., ISACKSON, P.J., FABRAZZO, M., FOLLESA, P., and MOCCHETTI, I. (1995). Induction of nerve growth factor and basic fibroblast growth factor mRNA following clenbuterol: contrasting anatomical and cellular localization. Exp. Neurol. 133, 1-9.
76. HE, X., and ROSENFELD, M.G. (1991). Mechanisms of complex transcriptional regulation: Implication for brain development. Neuron 7, 183-196.
77. HEFTI, F. (1986). Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6, 2155-2162.
78. HEFTI, F. (1994). Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25, 1418-1435.
79. HEMPSTEAD, B.L., MARTIN-ZANCA, D., KAPLAN, D.R., PARADA, L.F., and CHAO, M.V. (1991). High-affinity NGF binding requires coexpression of the trk protooncogene and the low affinity NGF receptor. Nature (London) 350, 678-683.
80. HENGERER, B., LINDHOLM, D., HEUMAN, R., RUTHER, U., WAGNER, E.F., and THOENEN, H. (1990). Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc. Natl. Acad. Sci. U.S.A. 87, 3899-3903.
81. HEUER, J., VON BARTHELD, C.S., KINOSHITA, Y., EVERS, S.P., and BOTHWELL, M., (1990). Alternating phases of FGF receptor and NGF receptor expression in the developing chicken nervous system. Neuron 5, 283-296.
82. HOFFMAN, D., BREAKEFIELD, X.O., SHORT, P., and AE-BISCHER, P. (1993). Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Exp. Neurol. 122, 100-106.
83. HOHN, A., LEIBROCK, J., BAILEY, K., and BARDE, Y-A. (1990). Identification and characterization of a novel member of the nerve growth factor/brain derived neurotrophic factor family. Nature (London) 344, 339-341.
84. HOLLBOOK, F., IBANEZ, C.F., and PERSSON, H. (1991). Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 6, 845-858.
85. HONORE, T., DAVIES, S.N., DREJER, J., et al. (1988). Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science 241, 701-703.
86. HYMAN, C., HOFER, M., BARDE, Y-A., et al. (1991). BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature (London) 350, 369-377.
87. IP, N., IBANEZ, C., NYE, S., et al. (1992). Mammalian neurotrophin-4: Structure, distribution and receptor specificity. Proc. Natl. Acad. Sci. U.S.A. 89, 3060-3064.
88. JOHNSON, E.M., TANIUCHI, M., and DI STEFANO, P. (1988). Expression and possible function of nerve growth factor receptor on Schwann cells. Trend Neurosci. 11, 299-304.
89. KAPLAN, D.R., and STEPHENS, R.M. (1994). Neurotrophin signal transduction by trk receptor. J. Neurobiol. 25, 1404-1417.
90. KAPLAN, D.R., HEMPSTEAD, B.L., MARTIN-ZANCA, D., CHAO, M.V., and PARADA, L. (1991a). The trk protooncogene product: A signal transduction receptor for nerve growth factor Science 252, 554-558.
91. KAPLAN, D.R., MARTIN-ZANCA, D., and PARADA, L.F. (1991b). Tyrosine phosphorylation and tyrosine kinase activity of the trk protooncogene product induced by NGF. Nature (London) 350, 158-160.
92. KASE, H., IWAHASHI, K., NAKANISHI, S., et al. (1987). K-252 compounds, novel and potent inhibitors of protein ki-nase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142, 436-440.
93. KLAGSBRUN, M., and BAIRD, A. (1991). A dual receptor system is required for basic fibroblast growth factor activity. Cell 67, 229-231.
94. KLEIN, R., JING, S., NANDURI, V., O-ROURKE, E., and BARB ACID, M. (1991). The trk protooncogene encodes a receptor for nerve growth factor. Cell 65, 189-197.
95. KNUSEL, B., MICHEL, P.P., SCHWABER, J.S., and HEFTI, F. (1990). Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10, 558-570.
96. KNUSEL, B., WINSLOW, J.W., ROSENTHAL, A., et al. (1991). Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not by neurotrophin-3. Proc. Natl. Acad. Sci. U.S.A. 88, 961-965.
97. KNUSEL, B., KAPLAN, D.R., WINSLOW, J.W., et al. (1992). K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin-3. J. Neurochem. 59, 715-722.
98. KOLIATSOS, V.E., NAUTA, H.J.W., CLATTERBUCK, R.E., MOBLEY, W.C., and PRICE, D.L. (1990). Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J. Neurosci. 10, 3801-3813.
99. KOLIATSOS, V.E., CLATTERBUCK, R.E., WINSLOW, J.W., CAYOUETTE, M.H., and PRICE, D.L. (1993). Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 10, 359-367.
100. KOSHINAGA, M., SANON, H.R., and WHITTEMORE, S.R. (1993). Altered acidic and basic fibroblast growth factor expression following spinal cord injury. Exp. Neurol. 120, 32-48.
101. KROMER, L.F. (1987). Nerve growth factor treatment after brain injury prevents neuronal death. Science 235, 214-216.
102. LAMBALLE, F., KLEIN, R., and BARBACID, M. (1991). trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 66, 967-979.
103. LEE, P.L., JOHNSON, D.E., COUSENS, L., FRIED, V.A., and WILLIAMS, L.T. (1989). Purification and complementary DNA cloning of receptor for basic fibroblast growth factor. Science 245, 57-60.
104. LEE, K.F., LI, E., HUBER, L.J., et al. (1992). Target mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral nervous system. Cell 69, 737-749.
105. LIN, L-F., DOHERTY, D.H., LILE, J.D., BEKTESH, S., and COLLINS, F. (1993). GDNF: A glial cell line-derived neu-rotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1134.
106. LIU, D., THANGNIPON, W., and MCADOO, D.J. (1991). Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res. 547, 344-348.
107. LOEB, D.M., and GREENE, L.A. (1993). Transfection with trk restores “slow” NGF binding, efficient NGF uptake and multiple NGF responses to NGF-nonresponsive PC 12 cell mutants. J. Neurosci. 13(7), 2919-2929.
108. LOEB, D.M., MARANGOS, J., MARTIN-ZANCA, D., CHAO, M.V., PARADA, L.F., and GREENE, L.A. (1991). The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC 12 cell line. Cell 66, 961-966.
109. LOGAN, A., FRAUTSCHY, S.A., GONZALES, A.M., and BAIRD, A. (1992). A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (fig) following a localized cortical brain injury. J. Neurosci. 12, 3828-3837.
110. LYONS, M.K., ANDERSON, R.E., and MEYER, F.B. (1991). Basic fibroblast growth factor promotes in vivo cerebral an-giogenesis in chronic forebrain ischemia. Brain Res. 558, 315-320.
111. MAIESE, K., BONIECE, I., DEMEO, D., and WAGNER, J.A. (1993). Peptide growth factor protect against ischemia in culture by preventing nitric oxide toxicity. J. Neurosci. 13, 3034-3040.
112. MAISONPIERRE, P.C., BELLUSCIO, L., SQUINTO, S., et al. (1990). Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science 247, 1446-1451.
113. MARTIN-ZANCA, D., OSKAM, R., MITRA, G., COPELAND, T., and BARBACID, M. (1989). Molecular and biochemical characterization of the human trk protooncogene. Mol. Cell Biol. 9, 24-33.
114. MARTIN-ZANCA, D., KAPLAN, D.R., PARADA, L.F., and CHAO, M.V. (1991). High-affinity NGF binding requires coexpression of the trk protooncogene and the low affinity NGF receptor. Nature (London) 350, 678-683.
115. MARTINEZ-MURILLO, R., CARO, L., and NIETO-SAM-PREDO, M. (1993). Lesion induced expression of low-affin-ity nerve growth factor receptor-immunoreactive protein in Purkinje cells of the adult rat. Neuroscience 52, 587-593.
116. MATTSON, M.P., and RYCHLIK, B. (1990). Glia protect hippocampal neurons against excitatory amino acid-induced degeneration: Involvement of fibroblast growth factor. Int. J. Dev. Neurosci. 8, 399-415.
117. MATTSON, M.P., and SCHEFF, S.W. (1994). Endogenous neuroprotection factors and traumatic brain injury mechanisms of action and implication for therapy. J. Neurotrauma 11, 3-33.
118. MCNEIL, P.L., MUTHUKRISHANAN, L., WADER, E., and D-AMORE, P.A. (1989). Growth factors are released by me-chanically wounded endothelial cells. J. Cell Biol. 109, 811-822.
119. MEAKIN, S.O., SUTER, U., DRINKWATER, C.C., WELCHER, A.A., and SHOOTER, E.M. (1992). The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 2374-2378.
120. METSIS, M., TIMMUSK, T., ALLIKMETS, R., SAARMA, M., and PERSSON, H. (1992). Regulatory elements and transcriptional regulation by testosterone and retinoic acid of the rat nerve growth factor promoter. Gene 64, 247-254.
121. MOCCHETTI, I. (1991). Theoretical basis for a pharmacology of nerve growth factor biosynthesis. Annu. Rev. Pharmacol. Toxicol. 32, 303-328.
122. MOCCHETTI, I., DE BERNARDI, M.A., SZEKELY, A.M., ALHO, H., BROOKER, G., and COSTA, E. (1989). Regulation of NGF biosynthesis by betα-adrenergic receptor activation in astrocytoma cells: A potential role of c-Fos protein. Proc. Natl. Acad. Sci. U.S.A. 86, 3891-3895.
123. MORGAN, J.I., COHEN, D.R., HEMPSTEAD, J.L., and CURRAN, T. (1987). Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237, 192-197.
124. MORRISON, R.S., SHARMA, A., DE VELLIS, J., and BRADSHAW, R.A. (1986). Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl. Acad. Sci. U.S.A. 83, 7537-7541.
125. NEAR, S.L., WHALEN, L.R., MILLER, J.A., and NISHII, D.N. (1992). Insulin-like growth factor II stimulates motor nerve regeneration. Proc. Natl. Acad. Sci U.S.A. 89, 11716-11720.
126. NIETO-SAMPEDRO, M., MANTORPE, M., BARBIN, G., VARON, S., and COTMAN, C.W. (1983). Injury-induced neurotrophic activity in adult rat brain. Correlation with survival of delayed implants in a wound cavity. J. Neurosci. 3, 2219-2229.
127. NOBLE, L.J., and WRATHALL, J.R. (1989). Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat. Exp. Neurol. 103, 34-40.
128. OPPENHEIM, R.W., PREVETTE, D., QIN-WEI, Y., COLLINS, F., and MACDONALD, J. (1991). Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 251, 1616-1618.
129. OPPENHEIM, R.W., HOUENOU, L.J., JOHNSON, J.E., et al. (1995). Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature (London) 373, 343-346.
130. OTTO, D., and UNSICKER, K. (1990). Basic FGF reverses chemicall and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10, 1912-1921.
131. OTTO, D., UNSICKER, K., and GROTHE, C. (1988). Basic fibroblast growth factor and nerve growth factor administered in gel foam rescue medial septal neurons after fimbria fornix transection. J. Neurosci. Res. 22, 83-91.
132. RABIN, S.J., and MOCCHETTI, I. (1995). GM1 Ganglioside activates the high affinity nerve growth factor receptor TrkA. J. Neurochem. 65, 347-354.
133. RABIN, S.J., CLEGHON, V., and KAPLAN, D.R. (1993). SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC 12 cells. Mol. Cell Biol. 13, 2203-2213.
134. RADEKE, M.J., MISKO, T.P., HSU, C., HERENBERG, L.A., and SHOOTER, E.M. (1987). Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature (London) 325, 593-597.
135. RENKO, M., QUARTO, N., MORIMOTO, T., and RIFKIN, D.B. (1990). Nuclear and cytoplasmatic localization of different basic fibroblast growth factor species. J. Cell Physiol. 44, 108-114.
136. REYNOLDS, M.E., BRUNELLO, N., MOCCHETTI, I., and WRATHALL, J.R. (1991). Localization of nerve growth factor mRNA in contused rat spinal cord by in situ hybridization. Brain Res. 559, 149-153.
137. RIFKIN, D.B., and MOSCATELLI, D. (1989). Recent development in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109, 1-6.
138. RIVA, M., and MOCCHETTI, I. (1991). Developmental expression of the basic fibroblast growth factor gene in rat brain. Dev. Brain Res. 62, 45-50.
139. RIVA, M.A., GALE, K., and MOCCHETTI, I. (1992). Basic fibroblast growth factor mRNA increases in specific brain regions following convulsive seizures. Mol. Brain Res. 15, 311-318.
140. ROGHANI, M., and MOSCATELLI, D. (1992). Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J. Biol. Chem. 267, 22156-22161.
141. ROGHANI, M., MANSUKHANI, A., DELL-ERA, P., et al. (1994). Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269, 3976-3984.
142. ROSEMBERG, M.B., FRIEDMANN, T., ROBERTSON, R.C., WOLFF, J.A., BREAKEFIELD, X.O., and GAGE, F.H. (1988). Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science 242, 1575-1577.
143. SAPORITO, M.S., WILCOX, H.M.R., HARTPENCE, K.C., LEWIS, M.E., VAUGHT, J.L., and CARSWELL, S. (1993). Pharmacological induction of nerve growth factor mRNA in adult rat brain. Exp. Neurol. 123, 295-302.
144. SAPORITO, M.S., BROWN, E.R., HARTPENCE, K.C., et al. (1994). Systemic dexamethasone administration increases
145. septal trk autophosphorylation in adult rats via an induction of nerve growth factor. Mol. Pharmacol. 45, 395-401.
146. SCHNEIDER, J.S., POPE, A., SIMPSON, K., TAGGART, J., SMITH, M.G., and DI STEFANO, L. (1992). Recovery from experimental Parkinsonism in primates with GM1 ganglioside treatment. Science 256, 843-846.
147. SCHNELL, L., SCHNEIDER, R., KOLBECK, R., BARDE, Y.A., and SCHWAB, M.E. (1994). Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature (London) 345, 440-449.
148. SCHUBERT, D., LING, N., and BAIRD, A. (1987). Multiple influences of a Heparin-binding growth factor on neuronal development. J. Cell Biol. 104, 635-643.
149. SENDTNER, M., KREUTZBERG, G.M., and THOENEN, H. (1990). Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature (London) 345, 440-441.
150. SENDTNER, M., HOLTMANN, B., KOLBECK, R., THOENEN, H., and BARDE, Y-A. (1992). Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature (London) 360,757-759.
151. SHEARDOWN, M.J., NIELSEN, E.O., HANSEN, A.J., JACOBSEN, A.J., and HONORE, T. (1990). 2,3-dihydroxoxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247, 571-574.
152. SHELTON, D.L., and REICHARDT, L.F. (1986). Studies on the regulation of /3-nerve growth factor gene in the central nervous system: Level and regional distribution of NGF mRNA suggest that NGF functions as trophic factor for several distinct populations of neurons. Proc. Natl. Acad. Sci. U.S.A. 83, 2714-2718.
153. SHOOTER, E.M. (1989). The role of nerve growth factor in neuronal development, maintenance and regeneration, in: Fidia Research Foundation Neuroscience Award Lectures. Raven Press: New York, Vol. 3, pp. 21-51.
154. SKAPER, S.D., NEGRO, A., DAL TOSO, R., and FACCI, L. (1992). Recombinant human ciliary neurotrophic factor alters the threshold of hippocampal pyramidal neuron sensitivity to excitotoxin damage: Synergistic effects of mono-sialogangliosides. J. Neurosci. Res. 33, 330-337.
155. SPINA, M.B., SQUINTO, S.P., MILLER, J., LINDSAY, R.M., and HYMAN, C. (1992). Brain-derived neurotrophic factors protects dopamine neurons against 6-hydroxydopamine and N-metyl-4-phmylpiridinium ion toxicity: Involvement of glutatione system. J. Neurochem. 59, 99-106.
156. SPRANGER, M., LINDHOLM, D., BANDTLOW, C., et al. (1990). Regulation of nerve growth factor (NGF) synthesis in rat central nervous system: Comparison between the effects of interleukin-1 and various growth factors in astrocytes and in vivo. Eur. J. Neurosci. 2, 69-76.
157. SQUINTO, S.P., STITT, T.N., ALDRICH, T.H., et al. (1991). trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65, 885-893.
158. STACHOWIAK, M.K., MOFFETT, J., PUCHACZ, E., FLORKIEWICZ, R., and STACHOWIAK, E.K. (1994). Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J. Cell Biol. 127, 203-223.
159. SUN, F-Y., COSTA, E., and MOCCHETTI, I. (1993). Adrenal steroids mediate the increase of hippocampal nerve growth factor biosynthesis following bicuculline convulsions. Neuropsychopharmacology 8, 219-225.
160. SUTTER, A., RIOPELLE, R.J., HARRIS-WARRICK, R.M., and SHOOTER, E.M. (1979). Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo ganglia cells. J. Biol. Chem. 254, 5972-5982.
161. TANIUCHI, M., CLARK, H.B., SCHWEIZER, J.B., and JOHNSON, E.M. (1988). Expression of nerve growth factor receptors by Schwann cells of axotomized peripheral nerves: Ultrastructural location, suppression by axonal contact, and binding properties. J. Neurosci. 8, 664-681.
162. TATOR, C.H. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
163. TISCHLER, A.S., RUZICKA, L.A., and DOBNER, P.R. (1991). A protein kinase inhibitor, staurosporine, mimics nerve growth factor induction of neurotensin/neuromedin N gene expression. J. Biol. Chem. 266, 1141-1146.
164. TOMAC, A., LINDQVIST, E., LIN, L.-F., et al. (1995). Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (London) 373, 335-339.
165. TUSZYNSKI, M.H., U, H.S., AMARAL, D.G., and GAGE, F.H. (1990). Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J. Neurosci. 10, 3604-3614.
166. ULLRICH, A., and SCHLESSINGER, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
167. URCA, G., and URCA, R. (1990). Neurotoxic effects of excitatory amino acids in the mouse spinal cord; quisqualate and kainate but not N-methyl-D-aspartate induce permanent neural damage. Brain Res. 529, 7-15.
168. VERDI, J.M., BIRREN, S.J., IBANEZ, C.F., et al. (1994). p75LNGFR regulates Trk signal transduction and NGF-in-duced neuronal differentiation in MAH cells. Neuron 12, 10-20.
169. VLODAVSKY, I., FOLKMAN, J., SULLIVAN, R., et al. (1987). Endothelial cell derived bFGF: Synthesis and deposition into subcellular extracellular matrix. Proc. Natl. Acad. Sci. U.S.A. 84, 2292-2296.
170. WALICKE, P.A. (1988). Basic and acidic fibroblast growth factor have trophic effect on neurons from multiple CNS regions. J. Neurosci. 8, 2618-2627.
171. WALICKE, P.A., and BAIRD, A. (1991). Internalization and processing of basic fibroblast growth factor by neurons and astrocytes. J. Neurosci. 11, 2249-2258.
172. WALICKE, P., COWAN, W.M., UENO, N., BAIRD, A., and GUILLEMIN, R. (1986). Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extention. Proc. Natl. Acad. Sci. U.S.A. 83, 3012-3016.
173. WANAKA, A., MILBRANDT, J., and JOHNSON, E.M. (1991). Expression of FGF receptor gene in rat development. Development 111, 455-468.
174. WHITTEMORE, S.R., and SEIGER, A. (1987). The expression, localization and functional significance of /3-nerve growth factor in the central nervous system. Brain Res. Rev. 12, 349-464.
175. WIDMER, H.R., KNUSEL, B., and HEFTI, F. (1993). BDNF protection of basal forebrain cholinergic neurons after axo-tomy: Complete protection of p75NGFR-positive neurons. Neuroreport 4, 363-366.
176. WILLIAMS, L.R., VARON, S., PETERSON, G.M., et al. (1986). Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. U.S.A. 83, 9231-9235.
177. WOODWARD, W.R., NISHI, R., MESHUL, C.K., WILLIAMS, T.E., COULOMBE, M., and ECKENSTEIN, F.P. (1992). Nuclear and cytoplasmic localization of bFGF in astrocytes and CA2 hippocampal neurons. J. Neurosci. 12, 142-153.
178. WRATHALL, J.R., PETTEGREW, R.K., and HARVEY, F. (1985). Spinal cord contusion in the rat: Production of graded, reproducible injury groups. Exp. Neurol. 88, 108-122.
179. WRATHALL, J.R., BOUZOUKIS, J., and CHOINIERE, D. (1992a). Effect of kynurenate on functional deficit from traumatic spinal cord injury. Eur. J. Pharmacol. 218, 273-281.
180. WRATHALL, J.R., TENG, Y.D., CHOINIERE, D., and MUNDT, E. (1992b). Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury. Brain Res. 586, 140-143.
181. WRATHALL, J.R., CHOINIERE, D., and TENG, Y.D. (1994). Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J. Neurosci. 14, 6598-6607.
182. YAKOVLEV, A.G., DEBERNARDI, M.A., FABRAZZO, M., BROOKER, G., COSTA, E., and MOCCHETTI, I. (1990). Regulation of nerve growth factor receptor mRNA by dex-amethasone: In vitro and in vivo studies. Neurosci. Lett. 116, 216-220.
183. YAN, Q., ELLIOT, J., and SNIDER, W.D. (1992). Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature (London) 360, 753-755.
184. YAN, Q., MATHESON, C., and LOPEZ, O.T. (1995). In vivo neurotrophic effects of gdnf on neonatal and adult facial motor neurons. Nature (London) 373, 341-344.
185. YOUNG, W. (1993). Nonregenerative approaches to spinal cord injury, in: Neuroregeneration. A. Gorio (ed.). Raven Press: New York, pp. 169-184.
186. ZHENG, M., and HEINRICH, G. (1988). Structural and functional analysis of the promoter region of the nerve growth factor gene. Mol. Brain Res. 3, 133-140.